Nuclear Medicine: Current Status and Trends in Radionuclide Therapy

Read full text
Authors: V.V. Krylov, O. V. Valzdorf, T. Yu. Kochetova
Cited by: 0
References: 4

Abstract

Nuclear medicine is currently undergoing a tremendous boom. The use of radiopharmaceuticals (RPHs) for the diagnostics & treatment of various diseases in routine medical practice is becoming increasingly widespread, significantly enhancing the overall efficacy of the treatment process. Currently the possibility to manufacture radiopharmaceuticals in-house, at hospital radiopharmacies, provides the domestic hospitals with the opportunity to use new highly effective, yet unregistered, radiopharmaceticals. They are based on radionuclides produced in Russia (such as 177 Lu, 225 Ac etc.)

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Medical Imaging Techniques and Applications Neuroendocrine Tumor Research Advances

Publication details

Journal / source
Journal of oncology diagnostic radiology and radiotherapy
Volume
8
Issue
4
Pages
38–49
Publication date
3 January 2026